New combo attack on lung cancer brain tumors shows promise in early trial
Disease control
Recruiting now
This study tests whether combining a targeted drug (adagrasib) with precise radiation (SRS) can better control brain metastases in people with a specific type of lung cancer (KRAS G12C-mutated NSCLC). About 30 adults with untreated brain tumors will receive both treatments. The m…
Phase: PHASE2 • Sponsor: Ryan Gentzler, MD • Aim: Disease control
Last updated May 15, 2026 11:53 UTC